The QoL was significantly lower in ≥ 40 years old patients (p <0.05), durations of disease ≥ 5 years (p <0.01), having comorbidities (p<0.05), SLEDAI score ≥ 5 (p<0.01) and having more than 4 clinical manifestions (p<0.05).